Some sarcoma subtypes such as synovial sarcoma and myxoid/round cell liposarcoma characterized as “cold” tumours without high expression of MHC-I and T-cells infiltration, may turn into hot tumours by IFNγ and thus may benefit from combination treatment with IFNγ and other immunotherapy strategies. This evidence concerns the gene IFNG and synovial sarcoma.